AcaHealth Pharma & Biotech Co.,LTD

長安醫藥生技 Innovative R&D

About us

AH-101-CVD was granted from US FDA for clinical trial in Jan, 23,2020. The application for IND to TFDA is ongoing in Apr, 2020.